https://www.youtube.com/watch?v=nAhCKKVMusg
Robert Carlson, MD, of the Stanford Comprehensive Cancer Center, an expert in breast cancer treatment, answers what is triple negative breast cancer and expl

https://www.youtube.com/watch?v=fwpO7PYXypA
Only 10% to 20% of breast cancers are triple-negative, but they tend to be more aggressive. Laura Pearson, M.D, explains what you need to know about triple-n

https://www.youtube.com/watch?v=_UqT2846QoU
What is triple-negative breast cancer and what are the treatment options? In this video, Dr. Jennifer Griggs provides a comprehensive guide and explains ever

https://www.mdanderson.org/cancerwise/triple-negative-breast-cancer-5-things-you-should-know.h00-158986656.html
Triple-negative breast cancer (TNBC) is a type of breast cancer that does not have the same receptors as most other types of breast cancer. It's an aggressive disease with a high rate of recurrence. Here, I'll share more about triple-negative breast cancer, including why the disease is more difficult to treat than other breast cancers, who's at greater risk for developing it and how

https://www.cdc.gov/cancer/videos/breast/linda-survivor-triple-negative/how-triple-negative-breast-cancer-treated/how-triple-negative-breast-cancer-treated-AD-transcript.pdf
o HER2. • A key (like hormone therapy or other drugs) for each lock show up. • Screenshot showing triple-negative breast cancer with keys and locks. The locks will turn to x's. • House with a lock for chemotherapy. Listen to Linda explain how triple-negative breast cancer is treated. She uses houses, locks, and keys to explain cancer

https://www.cancer.org/cancer/types/breast-cancer/about/types-of-breast-cancer/triple-negative.html
Triple-negative breast cancer (TNBC) is an aggressive type of invasive breast cancer. TNBC differs from other types of invasive breast cancer in that it tends to grow and spread faster, has fewer treatment options, and tends to have a worse prognosis (outlook). The term triple-negative breast cancer refers to the fact that the cancer cells don

https://www.hopkinsmedicine.org/health/conditions-and-diseases/breast-cancer/triple-negative-breast-cancer
What You Need to Know. Triple-negative breast cancer accounts for about 10% to 20% of all breast cancer cases. Every cancer diagnosis is unique, but in general, triple-negative breast cancer is a more aggressive type of tumor with a faster growth rate, higher risk of metastasis and recurrence risk. Therefore, it often requires chemotherapy as

https://www.keckmedicine.org/blog/triple-negative-breast-cancer-los-angeles-2024/
A USC Norris Comprehensive Cancer Center expert explains the diagnosis and latest treatment for triple-negative breast cancer. Triple-negative breast cancer is one of the least common types of breast cancer, only accounting for about 15% to 20% of all breast cancer diagnoses.It is one of the most aggressive subtypes of cancer that carries a high risk of metastasis.

https://cancerblog.mayoclinic.org/2024/04/25/new-study-finds-triple-negative-breast-cancer-tumors-with-an-increase-in-immune-cells-have-lower-risk-of-recurrence-after-surgery/
By Kelley Luckstein. A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates even when not treated with chemotherapy. The study was published today in the Journal of American Medical Association (JAMA).

https://www.mdanderson.org/cancer-types/breast-cancer/triple-negative-breast-cancer.html
What does triple-negative mean? "Triple-negative" refers to the lack of three specific molecules, called receptors, produced by the breast cancer cells. A cell's receptors interact or bind with specific proteins and hormones in the body. This is called recognition. Recognition sets many biological processes in motion.

https://www.kucancercenter.org/news-room/patient-stories/2019/10/triple-negative-breast-cancer-treatment
Schedule your mammogram. We find early-stage breast cancer at a rate that exceeds the national benchmark. Schedule your mammogram online today or call 913-588-1227. This individual participated in a clinical trial of an investigational treatment. Clinical trials are different from standard medical care.

https://www.onclive.com/view/a-brief-overview-of-treatment-options-for-triple-negative-breast-cancer
Traditionally, triple negative breast cancer has been treated with chemotherapy. Because it does not express ER, PR, HER2, chemotherapy has been the main state of management. However, with the

https://www.kucancercenter.org/cancer/cancer-types/breast-cancer/breast-cancer-types/triple-negative-breast-cancer
Clinical trials give you an opportunity to receive new therapies that might not otherwise be available. Search our clinical trials. To request an appointment, call 844-323-1227. Triple-negative breast cancer treatment and clinical trials are a key focus for the team at The University of Kansas Cancer Center, serving the Kansas City metro region.

https://www.youtube.com/watch?v=y28W4aKd1MI
Listen to Linda explain how triple-negative breast cancer is treated. She uses houses, locks, and keys to explain cancer cells, receptors, and treatment opti

https://www.goodrx.com/conditions/breast-cancer/triple-negative-treatment
Triple-negative breast cancer has unique characteristics that may limit treatment options. In this video, learn what therapies and medications work to treat this subtype of breast cancer, according to Amy Tiersten, MD, Oncologist and Hematologist at Dubin Breast Center at Mount Sinai Hospital in New York City. Amy Tiersten, MD Dr. Tiersten is a

https://www.cdc.gov/breast-cancer/about/triple-negative-breast-cancer.html
One is a protein called human epidermal growth factor ( HER2 ). If your cancer has any of these three locks, doctors have a few keys (like hormone therapy or other drugs) they can use to help destroy the cancer cells. But if you have triple-negative breast cancer, it means those three locks aren't there. So doctors have fewer keys for treatment.

https://www.targetedonc.com/expert-perspective-tumor-board/triple-negative-breast-cancer
Key opinion leaders review clinical cases in triple-negative breast cancer, focusing on recent advances, treatment options, and clinical trials impacting the treatment. ... Experts in breast cancer discuss efficacy data from the IMpassion130 clinical trial. Watch. EP. 3: ... An expert explains the different types of immune-related adverse

https://www.oncology-central.com/tvec-a-breakthrough-for-triple-negative-breast-cancer-patients/
Published in Nature Medicine, the study results assess the effectiveness of TVEC in combination with standard chemotherapy when given to 37 triple-negative breast cancer patients before surgery. Of the 37 patients that underwent treatment, 45.9% experienced a response, 89% were disease-free 2 years post-treatment and patients with a strong

https://www.self.com/story/triple-negative-breast-cancer-diagnosis
Brown-Tatum is far from the only person whose world shook after a triple negative breast cancer diagnosis. In July 2015, at 62, Deborah Smith was told she had stage IV metastatic triple negative

https://breastcancernow.org/information-support/publication/triple-negative-breast-cancer-bcn248
Triple negative breast cancer (BCN248) This booklet explains what triple negative breast cancer is, who it affects and how it can be treated. It includes information on treatments and further resources. Last reviewed May 2023, updated May 2023, next review 2025. Order a copy. Qty.

https://www.youtube.com/watch?v=5ULywn_l2cM
Researchers are actively looking for new treatments for triple-negative breast cancer, says Eric Winer, MD, chief of the Division of Women's Cancers at Dana-

https://www.medscape.com/recap/1000582
Key data on chemotherapy benefit in premenopausal women and improving survival in triple-negative breast cancer are among takeaways in early breast cancer from ASCO 2024 chosen by Dr Harold Burstein.

https://www.survivornet.com/articles/beloved-morning-show-legends-reunite-joan-lunden-73-and-charlie-gibson-81-will-take-the-stage-together-again/
Lunden was diagnosed with stage 2 triple-negative breast cancer in 2014. This type of breast cancer is more aggressive because it is unresponsive to certain targeted therapies, including hormone therapy or HER2-targeted agents like Herceptin; Chemotherapy is typically the primary treatment.

https://biosignaling.biomedcentral.com/articles/10.1186/s12964-024-01711-w
For example, triple-negative breast cancer (TNBC) cells can promote M1-to-M2 conversion by secreting significant levels of granulocyte-colony stimulating factor . M2-like TAMs increase hypoxia and aerobic glycolysis (the Warburg effect) in the TME, thus inhibiting the activation of CD4 + and CD8 + T effector cells, which are highly demanding

https://www.youtube.com/watch?v=RuOo_be7ki0
Triple-negative breast cancer (TNBC) makes up about 10% to 15% of breast cancer diagnoses and tends to be more aggressive than other breast cancers.In this v

https://www.bioworld.com/articles/709895-g1s-phase-iii-misses-in-triple-negative-breast-cancer
Top-line phase III data from G1 Therapeutics Inc.'s pivotal Preserve 2 study of Cosela (trilaciclib) in treating metastatic triple-negative breast cancer missed its primary endpoint of overall survival, submerging the stock on June 24.

https://www.nature.com/articles/s41419-024-06822-3
To accomplish this, Fas distribution in glioblastoma (U87), lung carcinoma (A549), liver carcinoma (HepG2), prostate cancer (PC3), and triple-negative breast cancer (SUM159) cells and in

https://www.nature.com/articles/s41568-024-00708-4
Psychological and social factors can have major and wide-ranging impacts on patients with incurable cancer. This manifests in more than threefold higher suicide rates 145,146,147.Of note, these

https://www.youtube.com/shorts/sEExjGznwTs
In this video, Dr. Jennifer Griggs explains triple-negative breast cancer and its unique traits. Get your Yerbba Report at https://app.yerbba.com/signup to a